Jan 3 (Reuters) - Eton Pharmaceuticals Inc ETON.O:
ETON PHARMACEUTICALS ADVANCES ITS COMMITMENT TO RARE DISEASE WITH THE ACQUISITION OF GALZIN®
ETON PHARMACEUTICALS INC - TO COMMERCIALIZE GALZIN IN U.S. IN Q1 2025
ETON PHARMACEUTICALS INC: HAS ALSO ACQUIRED EUROPEAN RIGHTS TO GALZIN
Source text: ID:nGNX1LkkCW
Further company coverage: ETON.O
((Reuters.Briefs@thomsonreuters.com;))